0.9(top 50%)
impact factor
960(top 20%)
papers
12.5K(top 20%)
citations
43(top 20%)
h-index
0.9(top 50%)
impact factor
1.0K
all documents
12.9K
doc citations
64(top 20%)
g-index

Top Articles

#TitleJournalYearCitations
1Understanding the Fundamentals of Perfluorocarbons and Perfluorocarbon Emulsions Relevant toIn VivoOxygen DeliveryArtificial Cells, Blood Substitutes, and Biotechnology2005290
2Medical Application of Microbial Biopolyesters PolyhydroxyalkanoatesArtificial Cells, Blood Substitutes, and Biotechnology2009198
3Perfluorocarbon-based Oxygen DeliveryArtificial Cells, Blood Substitutes, and Biotechnology2006189
4Pharmacokinetics and Side Effects of Perfluorocarbon-Based Blood SubstitutesArtificial Cells, Blood Substitutes, and Biotechnology1994139
5Exploratory Design in Medical Nanotechnology: A Mechanical Artificial Red CellArtificial Cells, Blood Substitutes, and Biotechnology1998125
6Nanomaterials as Matrices for Enzyme ImmobilizationArtificial Cells, Blood Substitutes, and Biotechnology2011125
7Generation of Alginate-Poly-L-Lysine-Alginate (APA) Biomicrocapsules: the Relationship Between the Membrane Strength and the Reaction ConditionsArtificial Cells, Blood Substitutes, and Biotechnology199494
8Hemoglobin Autooxidation/Oxidation Mechanisms and Methemoglobin Prevention or Reduction Processes in the Bloodstream Literature review and outline of autooxidation reactionArtificial Cells, Blood Substitutes, and Biotechnology199887
9Hemoglobin Based Oxygen Carriers: How Much Methemoglobin is too Much?Artificial Cells, Blood Substitutes, and Biotechnology199884
10Advances in Novel Drug Delivery Strategies for Breast Cancer TherapyArtificial Cells, Blood Substitutes, and Biotechnology201084
11CROSS-LINKED POLYHEMOGLOBIN-SUPEROXIDE DISMUTASE-CATALASE SUPPLIES OXYGEN WITHOUT CAUSING BLOOD BRAIN BARRIER DISRUPTION OR BRAIN EDEMA IN A RAT MODEL OF TRANSIENT GLOBAL BRAIN ISCHEMIA-REPERFUSIONArtificial Cells, Blood Substitutes, and Biotechnology200277
12Heme and the Vasculature: an Oxidative Hazard that Induces Antioxidant Defenses in the EndotheliumArtificial Cells, Blood Substitutes, and Biotechnology199476
13Submicron Polymer Membrane Hemoglobin Nanocapsules as Potential Blood Substitutes: Preparation and CharacterizationArtificial Cells, Blood Substitutes, and Biotechnology199674
14Encapsulation of Human Islets in Novel Inhomogeneous Alginate-Ca2+/Ba2+Microbeads:In VitroandIn VivoFunctionArtificial Cells, Blood Substitutes, and Biotechnology200874
15Analysis of Polyethylene‐glycol‐polylactide Nano‐Dimension Artificial Red Blood Cells in Maintaining Systemic Hemoglobin Levels and Prevention of Methemoglobin FormationArtificial Cells, Blood Substitutes, and Biotechnology200371
16Review of Hemoglobin-Induced Myocardial LesionsArtificial Cells, Blood Substitutes, and Biotechnology200471
17Characterization of Processed Tooth Hydroxyapatite for Potential Biomedical Implant ApplicationsArtificial Cells, Blood Substitutes, and Biotechnology199970
18Recent and Future Developments in Modified Hemoglobin and Microencapsulated Hemoglobin as Red Blood Cell SubstitutesArtificial Cells, Blood Substitutes, and Biotechnology199769
19Encapsulation of Enzymes in Liposomes: High Encapsulation Efficiency and Control of Substrate PermeabilityArtificial Cells, Blood Substitutes, and Biotechnology200466
20An Amperometric Biosensor for Uric Acid Determination Prepared from Uricase Immobilized in Polypyrrole FilmArtificial Cells, Blood Substitutes, and Biotechnology200665
21The Potential Role of Perfluorochemicals (PFCS) in Diagnostic ImagingArtificial Cells, Blood Substitutes, and Biotechnology199464
22CALCULATIONS OF OXYGEN TRANSPORT BY RED BLOOD CELLS AND HEMOGLOBIN SOLUTIONS IN CAPILLARIESArtificial Cells, Blood Substitutes, and Biotechnology200261
23Controlled Release of Endothelial Cell Growth Factor from Chitosan-Albumin Microspheres for Localized Angiogenesis: In Vitro and in Vivo StudiesArtificial Cells, Blood Substitutes, and Biotechnology199660
24Lyophilized Platelets: Fifty Years in the MakingArtificial Cells, Blood Substitutes, and Biotechnology200760
25A First Evaluation of the Natural High Molecular Weight Polymeric Lumbricus terrestris Hemoglobin as an Oxygen CarrierArtificial Cells, Blood Substitutes, and Biotechnology199758
26Effect of Surfactants on the Characteristics of Fluconazole Niosomes for Enhanced Cutaneous DeliveryArtificial Cells, Blood Substitutes, and Biotechnology201158
27Use ofOxygent™, A Perfluorochemical-Based Oxygen Carrier, as An Alternative to Intraoperative Blood TransfusionArtificial Cells, Blood Substitutes, and Biotechnology199556
28Nitric Oxide Mediates the Hypertensive Response to a Modified Hemoglobin Solution (DCLHBTH) in RatsArtificial Cells, Blood Substitutes, and Biotechnology199455
29Characterization of the Hemodynamic Response to Intravenous Diaspirin Crosslinked Hemoglobin Solution in RatsArtificial Cells, Blood Substitutes, and Biotechnology199454
30Influence of Perflubron Emulsion Particle Size on Blood Half-Life and Febrile Response in RatsArtificial Cells, Blood Substitutes, and Biotechnology199454
31Clinical Results of Perftoran Application: Present and FutureArtificial Cells, Blood Substitutes, and Biotechnology200554
32In VitroComparison of Dodecafluoropentane (DDFP), Perfluorodecalin (PFD), and Perfluoroctylbromide (PFOB) in the Facilitation of Oxygen ExchangeArtificial Cells, Blood Substitutes, and Biotechnology200953
33From artificial red blood cells, oxygen carriers, and oxygen therapeutics to artificial cells, nanomedicine, and beyondArtificial Cells, Blood Substitutes, and Biotechnology201252
34Potential Use of Collagen-Chitosan-Hyaluronan Tri-Copolymer Scaffold for Cartilage Tissue EngineeringArtificial Cells, Blood Substitutes, and Biotechnology200650
35Crosslinked Hemoglobin-Superoxide Dismutase-Catalase Scavenges Free Radicals in a Rat Model of Intestinal Ischemia-Reperfusion InjuryArtificial Cells, Blood Substitutes, and Biotechnology199748
36ROLE OF REDOX POTENTIAL OF HEMOGLOBIN-BASED OXYGEN CARRIERS ON METHEMOGLOBIN REDUCTION BY PLASMA COMPONENTSArtificial Cells, Blood Substitutes, and Biotechnology200247
37E. coliK-12 Asparaginase-Based Asparagine Biosensor for LeukemiaArtificial Cells, Blood Substitutes, and Biotechnology200746
38An Amperomertic Uric Acid Biosensor Based on Immobilization of Uricase onto Polyaniline-multiwalled Carbon Nanotube Composite FilmArtificial Cells, Blood Substitutes, and Biotechnology201046
39Advances in Pulmonary Delivery of NanoparticlesArtificial Cells, Blood Substitutes, and Biotechnology201246
40A New Theory of Enterorecirculation of Amino Acids and its use for Depleting Unwanted Amino Acids Using Oral Enzyme-Artificial Cells, as in Removing Phenylalanine in PhenylketonuriaArtificial Cells, Blood Substitutes, and Biotechnology199545
41Advanced Fluorocarbon-Based Systems for Oxygen and Drug Delivery, and DiagnosisArtificial Cells, Blood Substitutes, and Biotechnology199745
42Binding Mechanism of Heavy Metals Biosorption by Pycnoporus SanguineusArtificial Cells, Blood Substitutes, and Biotechnology199944
43FT-IR of membranes made with alginate/polylysine complexes. Variations with the mannuronic or guluronic content of the polysaccharidesArtificial Cells, Blood Substitutes, and Biotechnology199443
44Submicron Biodegradable Polymer Membrane Hemoglobin Nanocapsules as Potential Blood Substitutes: A Preliminary ReportArtificial Cells, Blood Substitutes, and Biotechnology199443
45Protein Engineering Strategies for Designing More Stable Hemoglobin-based Blood SubstitutesArtificial Cells, Blood Substitutes, and Biotechnology199743
46Synthesis, Characterization, Biodegradation, and Drug Delivery Application of Biodegradable Lactic/Glycolic Acid Polymers: Part III. Drug Delivery ApplicationArtificial Cells, Blood Substitutes, and Biotechnology200443
47Engineering of Rat Articular Cartilage on Porous Sponges: Effects of TGF-β 1and Microgravity Bioreactor CultureArtificial Cells, Blood Substitutes, and Biotechnology200842
48Comparing the Chondrogenic Potential in vivo of Autogeneic Mesenchymal Stem Cells Derived from Different TissuesArtificial Cells, Blood Substitutes, and Biotechnology201142
49Decreased Agglutinability of Methoxy-Polyethylene Glycol Attached Red Blood Cells: Significance as a Blood SubstituteArtificial Cells, Blood Substitutes, and Biotechnology199641
50A Method for Purification and Viral Inactivation of Human Placenta HemoglobinArtificial Cells, Blood Substitutes, and Biotechnology200641